Know Cancer

or
forgot password

    • cancer clinical trials in pittsfield, MA

    • Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    Berkshire Medical Center
    Pittsfield, Massachusetts 01201
    Colorectal Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Breast Cancer
    Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Berkshire Physicians and Surgeons, P.C.
    Pittsfield, Massachusetts 01201
    Lung Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Berkshire Hematology Oncology, P.C.
    Pittsfield, Massachusetts 01201
    Colorectal Cancer
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Berkshire Hematology Oncology/Bershire Medical Center
    Pittsfield, Massachusetts 01201
    Alzheimer Disease
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Breast Cancer
    GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
    GSK Clinical Trials Call Center
    Pittsfield, Massachusetts 01201
    Colorectal Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Esophageal Cancer, Gastric Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab
    GSK Clinical Trials Call Center
    Pittsfield, Massachusetts 01201
    Non-Hodgkin's Lymphoma
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Breast Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients
    Berkshie Hematology Oncology
    Pittsfield, Massachusetts 01201
    Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Colorectal Cancer, Precancerous Condition
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    A Safety and Efficacy Study of Farletuzumab in Subjects With Adenocarcinoma of the Lung
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Adenocarcinoma of the Lung
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
    Berkshire Medical Center
    Pittsfield, Massachusetts 01201
    Breast Cancer
    Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
    Berkshire Medical Center
    Pittsfield, Massachusetts 01201
    Breast Cancer
    Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
    Berkshire Medical Center
    Pittsfield, Massachusetts 01201
    Breast Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Berkshire Physicians and Surgeons, P.C.
    Pittsfield, Massachusetts 01201
    Breast Cancer
    Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
    Berkshire Physicians and Surgeons, P.C.
    Pittsfield, Massachusetts 01201
    Pancreatic Cancer
    A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
    "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
    Pittsfield, Massachusetts
    Colorectal Cancer
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    Berkshire Hematology & Oncology, PC
    Pittsfield, Massachusetts 012018298
    Pancreatic Cancer
    Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
    GSK Clinical Trials Call Center
    Pittsfield, Massachusetts 01201
    Small Cell Lung Cancer
    Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Non-small Cell Lung Cancer
    REST: Reducing End-of-Life Symptoms With Touch
    Hospice Care in the Berkshires, Inc.
    Pittsfield, Massachusetts 01201
    Neoplasms, Pain
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Berkshire Hematology Oncology
    Pittsfield, Massachusetts 01201
    Prostate Cancer, Hormone Refractory Prostate Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Non Small Cell Lung Carcinoma
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Carcinoma, Non-Small-Cell Lung
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Lung Cancer, Non-small-cell Lung Carcinoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Berkshire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer
    Berskhire Hematology Oncology PC
    Pittsfield, Massachusetts 01201
    Advanced Unresectable Pancreatic Cancer
    Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Patients
    Berkshire Hematology Oncology
    Pittsfield, Massachusetts 01201
    Multiple Myeloma
    Cognition in the Study of Tamoxifen and Raloxifene
    Berkshire Hematology Oncology, P.C.
    Pittsfield, Massachusetts 01201
    Cognition, Aging
    Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
    Berkshire Hematology Oncology, PC
    Pittsfield, Massachusetts 01201
    Colorectal Cancer, Metastatic Cancer